Alterity Therapeutics (ATHE) Asset Utilization Ratio (2011 - 2025)
Alterity Therapeutics (ATHE) recorded quarterly Asset Utilization Ratio of 0.55 in Q4 2025, down 70.26% quarter-over-quarter from 1.83 in Q4 2024, and down 70.26% on a YoY basis from 1.83 in Q4 2024.
Alterity Therapeutics (ATHE) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
Alterity Therapeutics' Asset Utilization Ratio history runs 11 years deep, the most recent figure standing at 0.55 for Q4 2025.
- In Q4 2025, Asset Utilization Ratio fell 70.26% year-over-year to 0.55; the TTM figure through Dec 2025 stood at 0.55 (down 70.26% YoY), while the FY2023 annual figure was 235298.95, changed N/A from the prior year.
- Asset Utilization Ratio was 0.55 for Q4 2025 at Alterity Therapeutics, down from 1.83 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 340753691323.46 in Q2 2024 to a low of 0.44 in Q4 2021.
- Historically, Asset Utilization Ratio has averaged 48679123768.0 across 5 years, with a median of 0.97 in 2023.
- The sharpest annual moves came in 2021 and 2024: Asset Utilization Ratio tumbled 98.98% in 2021, then surged 194662838.89% in 2024.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.44 in 2021, then jumped by 51.0% to 0.66 in 2022, then soared by 47.99% to 0.97 in 2023, then jumped by 88.28% to 1.83 in 2024, then sank by 70.26% to 0.55 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.55 (Q4 2025), 1.83 (Q4 2024), and 340753691323.46 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 0.55 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | 0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.55 |
| Dec 31, 2024 | 1.83 |
| Jun 30, 2024 | 340.75 Bn |
| Dec 31, 2023 | 0.97 |
| Jun 30, 2023 | 175,048.06 |
| Dec 31, 2022 | 0.66 |
| Dec 31, 2021 | 0.44 |
| Dec 31, 2020 | 42.93 |
| Dec 31, 2019 | 0.90 |
| Dec 31, 2018 | 0.00 |
| Dec 31, 2017 | 0.00 |
| Dec 31, 2016 | 0.01 |
| Jun 30, 2011 | 24.28 |